A detailed history of China Universal Asset Management Co., Ltd. transactions in Grifols Sa stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 23,461 shares of GRFS stock, worth $155,781. This represents 0.02% of its overall portfolio holdings.

Number of Shares
23,461
Previous 23,461 -0.0%
Holding current value
$155,781
Previous $157,000 0.64%
% of portfolio
0.02%
Previous 0.02%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 29, 2024

BUY
$5.47 - $11.38 $51,144 - $106,403
9,350 Added 66.26%
23,461 $157,000
Q4 2023

May 21, 2024

SELL
$7.71 - $11.56 $72,088 - $108,086
-9,350 Reduced 39.85%
14,111 $163,000
Q4 2023

Jan 23, 2024

BUY
$7.71 - $11.56 $84,648 - $126,917
10,979 Added 350.54%
14,111 $163,000
Q3 2023

May 21, 2024

BUY
$8.91 - $10.91 $14,416 - $17,652
1,618 Added 106.87%
3,132 $28,000
Q3 2023

Oct 30, 2023

BUY
$8.91 - $10.91 $14,416 - $17,652
1,618 Added 106.87%
3,132 $29,000
Q2 2023

May 21, 2024

SELL
$7.14 - $9.29 $71 - $92
-10 Reduced 0.66%
1,514 $13,000
Q2 2023

Jul 27, 2023

SELL
$7.14 - $9.29 $71 - $92
-10 Reduced 0.66%
1,514 $14,000
Q1 2023

May 21, 2024

BUY
$6.65 - $10.69 $2,626 - $4,222
395 Added 34.99%
1,524 $11,000
Q1 2023

Apr 27, 2023

BUY
$6.65 - $10.69 $2,626 - $4,222
395 Added 34.99%
1,524 $11,000
Q4 2022

May 21, 2024

SELL
$5.96 - $8.53 $133,098 - $190,491
-22,332 Reduced 95.19%
1,129 $9,000
Q4 2022

Jan 31, 2023

BUY
$5.96 - $8.53 $512 - $733
86 Added 8.25%
1,129 $10,000
Q3 2022

Oct 21, 2022

BUY
$5.95 - $14.3 $6,205 - $14,914
1,043 New
1,043 $6,000

Others Institutions Holding GRFS

About Grifols SA


  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $4.51B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track This Portfolio

Track China Universal Asset Management Co., Ltd. Portfolio

Follow China Universal Asset Management Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of China Universal Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on China Universal Asset Management Co., Ltd. with notifications on news.